Glenohumeral Cortisone Injection

NCT04216017 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Humeral Fractures

Interventions

DRUG: kenalog
DRUG: Lidocaine

Sponsor

University of Washington

Collaborators

[object Object]